Article Text
PDF
Statistics from Altmetric.com
Footnotes
-
Contributors MS, individual contribution to the manuscript—Drafting, revising, conducting and reporting the manuscript's content, including medical writing of content. AD, individual contribution to the manuscript—Drafting, revising and planning the manuscript's content, including medical writing of content. BP, individual contribution to the manuscript—Drafting and reporting the manuscript's content. SAF, individual contribution to the manuscript—Revising the manuscript's content, including medical writing of content. DB-G, individual contribution to the manuscript—Conducting and revising the manuscript's content, including medical writing of content. MS and AD, are responsible for the overall content as guarantors.
-
Funding None.
-
Competing interests None.
-
Provenance and peer review Not commissioned. Externally peer reviewed. This paper was reviewed by Mark Lawden, Leicester, UK.
Request Permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information:
Read the full text or download the PDF:
Other content recommended for you
- Choroidal vascular remodelling in central serous chorioretinopathy after indocyanine green guided photodynamic therapy with verteporfin: a novel treatment at the primary disease level
- Photodynamic therapy for steroid - associated central serous chorioretinopathy
- Long - term efficacy of half - dose photodynamic therapy on chronic central serous chorioretinopathy
- Two - year follow - up of mineralocorticoid receptor antagonists for chronic central serous chorioretinopathy
- En face choroidal vascular feature imaging in acute and chronic central serous chorioretinopathy using swept source optical coherence tomography
- Near - infrared and short - wavelength autofluorescence imaging in central serous chorioretinopathy
- Safety enhanced photodynamic therapy with half dose verteporfin for chronic central serous chorioretinopathy: a short term pilot study
- Retinal and choroidal changes observed with ‘ En face ’ enhanced - depth imaging OCT in central serous chorioretinopathy
- Identifying central serous chorioretinopathy biomarkers in coexisting diabetic retinopathy: a multimodal imaging study
- Optical coherence tomography angiography of flat irregular pigment epithelial detachments in central serous chorioretinopathy